Cardiac Surgery News and Research

RSS

CryoLife acquires Cardiogenesis

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that it has successfully completed its acquisition of Cardiogenesis Corporation.

17 May 2011

AACN to honor 22 nurses nationwide with 2011 Circle of Excellence Award

The American Association of Critical-Care Nurses will bestow the 2011 Circle of Excellence Award on 22 nurses nationwide at the National Teaching Institute & Critical Care Exposition, Chicago, April 30-May 5.

30 Apr 2011

AACN to present Flame of Excellence Award to Baylor cardiovascular nurse specialist

The American Association of Critical-Care Nurses will present the Flame of Excellence Award to Barbara "Bobbi" Leeper, RN, MN, CNS M-S, CCRN, FAHA, cardiovascular clinical nurse specialist at Baylor University Medical Center, Dallas.

30 Apr 2011

Surgeons to participate in Methodist Hospital's Pumps & Pipes symposia

Surgeons from The Methodist DeBakey Heart & Vascular Center along with scientists and engineers from two of the nation's largest industries - medicine and energy will take part in the first international Pumps & Pipes symposia in Doha, Qatar on April 28 to explore the synergies in moving oil and pumping blood.

29 Apr 2011

MAQUET introduces new pediatric oxygenators and reservoirs in the U.S.

MAQUET Cardiovascular today announced the launch of its QUADROX-i Neonatal and Pediatric oxygenators and reservoirs in the United States. Oxygenators are an integral part of a cardiopulmonary bypass system and function as an artificial lung during surgical procedures.

27 Apr 2011

CryoLife's BioGlue Surgical Adhesive launched in Japan

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, today announced that its BioGlue Surgical Adhesive has launched in Japan and is expected to be available in hospitals by late May 2011.

25 Apr 2011

New research provides insight into mechanism behind cardiac development

During embryonic development, cells migrate to their eventual location in the adult body plan and begin to differentiate into specific cell types. Thanks to new research at the University of Pennsylvania, there is new insight into how these processes regulate tissues formation in the heart.

25 Apr 2011

Obese patients may face high risk of complications after non-cardiac surgery

Obese patients with high blood pressure and diabetes are at much higher risk for major complications following non-cardiac surgery compared to otherwise healthy obese patients and patients of normal weight.

19 Apr 2011

St. Jude Medical's Accent MRI pacemaker and Tendril MRI lead system receives European CE Mark approval

St. Jude Medical, Inc., a global medical device company, today announced that it has received European CE Mark approval for its Accent MRI™ pacemaker and Tendril MRI™ lead. The system, designed and tested for safe use in a Magnetic Resonance Imaging (MRI) environment and approved as MR-Conditional, allows patients to undergo full-body, high-resolution MRI scans.

18 Apr 2011

Patients with heart failure can benefit from left ventricular assist device

Non-cardiac surgery can be performed safely in patients with a heart device typically implanted into patients waiting for a transplant, according to a study at Henry Ford Hospital in Detroit.

15 Apr 2011

MR patients treated with Abbott MitraClip system demonstrate clinical benefits of initial treatment at two years

Abbott today announced data from its EVEREST II (Endovascular Valve Edge-to-Edge REpair STudy) study showing that patients with significant mitral regurgitation (MR) treated with the company's investigational percutaneous catheter-based MitraClip® system continue to demonstrate the clinical benefits of initial treatment shown at one year out to two years, including improvements in heart function and reductions in symptoms.

5 Apr 2011

Abbott launches MitraClip system to treat MR in Australia

Abbott today announced the launch of the company's catheter-based MitraClip system for the treatment of mitral regurgitation in Australia. The MitraClip device, which has received Therapeutic Goods Administration approval, offers a new treatment option for patients suffering from MR, a debilitating heart valve condition.

31 Mar 2011

CryoLife to acquire Cardiogenesis

CryoLife, Inc., an implantable biological medical device and cardiovascular tissue processing company, and Cardiogenesis Corporation, a leading developer of surgical products used in the treatment of patients with refractory angina resulting from diffuse coronary artery disease, today announced that the boards of directors of both companies have approved a definitive agreement under which CryoLife will acquire all of the outstanding shares of Cardiogenesis for $0.457 per share.

29 Mar 2011

FDA approves humanitarian device exemption for Elana Surgical Kit in cerebral bypass

Dutch medical device manufacturer, Elana bv, announced today that it has received approval from the U.S. Food and Drug Administration (FDA) for a humanitarian device exemption (HDE), enabling a lifesaving cerebral bypass. Elana bv is a corporate spin-off from the University Medical Centre Utrecht, the Netherlands.

25 Mar 2011

Mary Bridge, Seattle Children's partner to focus on pediatric cardiac surgery services

Seattle Children's Hospital and MultiCare Mary Bridge Children's Hospital today announced the formation of a new 10-year collaboration that will expand pediatric specialty services in the Puget Sound region. Initially, the new partnership will focus on providing cardiac surgery services for infants and children.

23 Mar 2011

STJ inaugurates Advanced Technology Center for physicians in Beijing

St. Jude Medical, Inc., a global medical device company, today celebrated the grand opening of the St. Jude Medical Advanced Technology Center Asia Pacific, located in Beijing, China.

22 Mar 2011

St. Jude Medical achieves 2 million mechanical heart valve implant milestone

St. Jude Medical, Inc., a global medical device company, today announced that the company will celebrate the treatment of more than 2 million patients with its mechanical heart valve technology. This milestone, a landmark achievement for prosthetic heart valves, demonstrates the company's commitment to cardiac surgery and improving patient outcomes.

16 Mar 2011

U-M's North Campus Research Complex gets first lab-based scientists

The first laboratory-based researchers have moved into the University of Michigan's North Campus Research Complex (NCRC), bringing with them cutting-edge research that uses stem cells to create new heart muscle and focuses on the crucial squeezing action of the heart.

9 Mar 2011

Refrigerated whole blood may have shelf life beyond current standard of 24 to 48 hours

In a finding that may potentially improve survival from war injuries and disasters, laboratory researchers report that refrigerated whole blood may have a shelf life well beyond the current standard of 24 to 48 hours.

24 Feb 2011

Cerebral oximetry provides new way to identify patient risk levels prior to cardiac surgery

Covidien (NYSE: COV), a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, today announced that its INVOS™ Cerebral/Somatic Oximeter can provide a simple, noninvasive way to help cardiac surgeons assess patients at risk for poor outcomes prior to surgery.

21 Feb 2011